Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     

  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     

  • Bitcoin GBP

    51,993.49
    +652.74 (+1.27%)
     

  • CMC Crypto 200

    1,334.09
    +21.47 (+1.64%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

New Strong Sell Stocks for October 19th

Zacks Equity Research
·1-min read

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Cubic Corporation CUB is the designer, integrator and operator of systems, products, and services for command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) customers. The Zacks Consensus Estimate for its current year earnings has been revised 1.9% downward over the last 30 days.

Skyline Champion Corporation SKY is a factory-built housing company. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.

CBL & Associates Properties, Inc. CBL is the owner and manager of a portfolio of market-dominant properties located in dynamic and growing communities. The Zacks Consensus Estimate for its current year earnings has been revised 27.6% downward over the last 30 days.

ADVERTISEMENT

Neurocrine Biosciences, Inc. NBIX is a commercial-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 4.4% downward over the last 30 days.

Delta Air Lines, Inc. DAL is a provider of scheduled air transportation for passengers and cargo. The Zacks Consensus Estimate for its current year earnings has been revised 10.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
Neurocrine Biosciences, Inc. (NBIX) : Free Stock Analysis Report
 
CBL Associates Properties, Inc. (CBL) : Free Stock Analysis Report
 
Skyline Corporation (SKY) : Free Stock Analysis Report
 
Cubic Corporation (CUB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research